Profound Medical (PROF) Non-Current Deffered Revenue (2018 - 2026)
Profound Medical (PROF) recorded quarterly Non-Current Deffered Revenue of $441000.0 in Q1 2026, up 13.66% quarter-over-quarter from $388000.0 in Q4 2025, and up 418.82% on a YoY basis from $85000.0 in Q1 2025.
Profound Medical (PROF) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
Profound Medical's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $441000.0 for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue rose 418.82% year-over-year to $441000.0; the TTM figure through Mar 2026 stood at $441000.0 (up 418.82% YoY), while the FY2025 annual figure was $388000.0, up 691.84% from the prior year.
- Non-Current Deffered Revenue was $441000.0 for Q1 2026 at Profound Medical, up from $388000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $764000.0 in Q4 2022 to a low of $49000.0 in Q4 2024.
- Historically, Non-Current Deffered Revenue has averaged $334625.0 across 5 years, with a median of $268000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue plunged 93.27% in 2024, then jumped 691.84% in 2025.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $764000.0 in 2022, then declined by 4.71% to $728000.0 in 2023, then slumped by 93.27% to $49000.0 in 2024, then surged by 691.84% to $388000.0 in 2025, then climbed by 13.66% to $441000.0 in 2026.
- The last three Non-Current Deffered Revenue figures came in at $441000.0 (Q1 2026), $388000.0 (Q4 2025), and $148000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Profound Medical | 246.10 Mn | 195.80 Mn | 3.83 Mn | 441,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441,000.00 |
| Dec 31, 2025 | 388,000.00 |
| Sep 30, 2025 | 148,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 728,000.00 |
| Dec 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 875,000.00 |
| Dec 31, 2020 | 1.08 Mn |
| Dec 31, 2019 | 628,723.64 |
| Jan 1, 2019 | 278,000.00 |
| Dec 31, 2018 | 287,171.24 |